534 related articles for article (PubMed ID: 19584304)
1. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
Nakatani T; Ohnishi M; Razzaque MS
FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304
[TBL] [Abstract][Full Text] [Related]
2. In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels.
Ohnishi M; Nakatani T; Lanske B; Razzaque MS
Circ Cardiovasc Genet; 2009 Dec; 2(6):583-90. PubMed ID: 20031638
[TBL] [Abstract][Full Text] [Related]
3. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6.
Uchihashi K; Nakatani T; Goetz R; Mohammadi M; He X; Razzaque MS
Contrib Nephrol; 2013; 180():124-37. PubMed ID: 23652555
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.
Martins JS; Liu ES; Sneddon WB; Friedman PA; Demay MB
Endocrinology; 2019 Oct; 160(10):2204-2214. PubMed ID: 31237611
[TBL] [Abstract][Full Text] [Related]
5. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
David V; Martin A; Hedge AM; Drezner MK; Rowe PS
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F783-91. PubMed ID: 21177780
[TBL] [Abstract][Full Text] [Related]
6. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
Ide N; Ye R; Courbebaisse M; Olauson H; Densmore MJ; Larsson TE; Hanai JI; Lanske B
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1261-F1270. PubMed ID: 29993278
[TBL] [Abstract][Full Text] [Related]
8. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
[TBL] [Abstract][Full Text] [Related]
9. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B
PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277
[TBL] [Abstract][Full Text] [Related]
10. Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
Memon F; El-Abbadi M; Nakatani T; Taguchi T; Lanske B; Razzaque MS
Kidney Int; 2008 Sep; 74(5):566-70. PubMed ID: 18528324
[TBL] [Abstract][Full Text] [Related]
11. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
[TBL] [Abstract][Full Text] [Related]
12. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
[TBL] [Abstract][Full Text] [Related]
13. Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.
Brownstein CA; Zhang J; Stillman A; Ellis B; Troiano N; Adams DJ; Gundberg CM; Lifton RP; Carpenter TO
Endocrinology; 2010 Feb; 151(2):492-501. PubMed ID: 19952276
[TBL] [Abstract][Full Text] [Related]
14. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
Li H; Martin A; David V; Quarles LD
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
[TBL] [Abstract][Full Text] [Related]
15. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
Ohnishi M; Razzaque MS
Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
17. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Ichikawa S; Austin AM; Gray AK; Econs MJ
J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
20. Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse.
Kaneko I; Segawa H; Ikuta K; Hanazaki A; Fujii T; Tatsumi S; Kido S; Hasegawa T; Amizuka N; Saito H; Miyamoto KI
Endocrinology; 2018 Jul; 159(7):2741-2758. PubMed ID: 29878089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
